ALK-IN-29
Product Specifications
Target
ALK, FAK, CDK
Related Pathways
Angiogenesis, Cell Cycle/Checkpoint, Cytoskeletal Signaling, Tyrosine Kinase/Adaptors
Bioactivity
ALK-IN-29 (compound 4c) exhibits inhibitory effects on tyrosine protein kinases such as ALK, CDK2/CyclinE1, and FAK, with the strongest inhibition observed against ALK kinase, displaying a 40.63% inhibition rate at a concentration of 10 μM. ALK-IN-29 is applicable in cancer research.
Molecular Formula
C29H32FN3O
Molecular Weight
457.58
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6477297-02 5x 0.1 mL
GABA A Receptor Associated Protein, NT (FITC)
Sign In for Pricing
View Details 244709-FITC 100 µL
CITED1 (Cbp/p300-Interacting transactivator, with Glu/Asp-Rich carboxy-terminal Domain, 1, MSG1) (FITC)
Sign In for Pricing
View Details